UBS Reiterates a 'Buy' on Gilead Sciences (GILD); Raises Numbers on Favorite Large-Cap Biotech
Go back to UBS Reiterates a 'Buy' on Gilead Sciences (GILD); Raises Numbers on Favorite Large-Cap Biotech| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 64.36 +0.53 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.83 | 52 Week High | $77.12 | |||
| Open | $63.60 | 52 Week Low | $49.03 | |||
| Day High | $64.53 | P/E | 41.79 | |||
| Day Low | $63.36 | EPS | $1.54 | |||
| Volume | 1,591,095 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 138.45 +0.09 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.36 | 52 Week High | $108.63 | |||
| Open | $138.36 | 52 Week Low | $71.39 | |||
| Day High | $139.49 | P/E | 76.49 | |||
| Day Low | $136.63 | EPS | $1.81 | |||
| Volume | 1,051,596 | |||||
